Skip to main content

Main menu

  • Home
  • Articles
    • Current Issue
    • Next in The JI
    • Archive
    • Brief Reviews
    • Pillars of Immunology
    • Translating Immunology
    • Most Read
    • Top Downloads
    • Annual Meeting Abstracts
  • COVID-19/SARS/MERS Articles
  • Info
    • About the Journal
    • For Authors
    • Journal Policies
    • Influence Statement
    • For Advertisers
  • Editors
  • Submit
    • Submit a Manuscript
    • Instructions for Authors
    • Journal Policies
  • Subscribe
    • Journal Subscriptions
    • Email Alerts
    • RSS Feeds
    • ImmunoCasts
  • More
    • Most Read
    • Most Cited
    • ImmunoCasts
    • AAI Disclaimer
    • Feedback
    • Help
    • Accessibility Statement
  • Other Publications
    • American Association of Immunologists
    • ImmunoHorizons

User menu

  • Subscribe
  • Log in

Search

  • Advanced search
The Journal of Immunology
  • Other Publications
    • American Association of Immunologists
    • ImmunoHorizons
  • Subscribe
  • Log in
The Journal of Immunology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Next in The JI
    • Archive
    • Brief Reviews
    • Pillars of Immunology
    • Translating Immunology
    • Most Read
    • Top Downloads
    • Annual Meeting Abstracts
  • COVID-19/SARS/MERS Articles
  • Info
    • About the Journal
    • For Authors
    • Journal Policies
    • Influence Statement
    • For Advertisers
  • Editors
  • Submit
    • Submit a Manuscript
    • Instructions for Authors
    • Journal Policies
  • Subscribe
    • Journal Subscriptions
    • Email Alerts
    • RSS Feeds
    • ImmunoCasts
  • More
    • Most Read
    • Most Cited
    • ImmunoCasts
    • AAI Disclaimer
    • Feedback
    • Help
    • Accessibility Statement
  • Follow The Journal of Immunology on Twitter
  • Follow The Journal of Immunology on RSS

Table of Contents

April 1, 1996; Volume 156,Issue 7

CUTTING EDGE

  • You have accessRestricted access
    CD40-mediated signaling in B cells. Balancing cell survival, growth, and death.
    M R Kehry
    J Immunol April 1, 1996, 156 (7) 2345-2348;
  • You have accessRestricted access
    B cell lineage-specific activator protein (BSAP). A player at multiple stages of B cell development.
    J S Michaelson, M Singh and B K Birshtein
    J Immunol April 1, 1996, 156 (7) 2349-2351;
  • You have accessRestricted access
    T cells commit suicide, but B cells are murdered!
    D W Scott, T Grdina and Y Shi
    J Immunol April 1, 1996, 156 (7) 2352-2356;
  • You have accessRestricted access
    Different susceptibility of cytotoxic T cells to CD95 (Fas/Apo-1) ligand-mediated cell death after activation in vitro versus in vivo.
    S Ehl, U Hoffmann-Rohrer, S Nagata, H Hengartner and R Zinkernagel
    J Immunol April 1, 1996, 156 (7) 2357-2360;
  • You have accessRestricted access
    Identification of MECL-1 (LMP-10) as the third IFN-gamma-inducible proteasome subunit.
    D Nandi, H Jiang and J J Monaco
    J Immunol April 1, 1996, 156 (7) 2361-2364;
  • You have accessRestricted access
    Complexes generated by the binding of free peptides to class II MHC molecules are antigenically diverse compared with those generated by intracellular processing.
    N J Viner, C A Nelson, B Deck and E R Unanue
    J Immunol April 1, 1996, 156 (7) 2365-2368;

ARTICLES

  • You have accessRestricted access
    Induction of cytotoxic T lymphocytes and antitumor immunity with DNA vaccines expressing single T cell epitopes.
    I F Ciernik, J A Berzofsky and D P Carbone
    J Immunol April 1, 1996, 156 (7) 2369-2375;
  • You have accessRestricted access
    IL-1 as systemic modifier of B lymphopoiesis. Recombinant IL-1 alpha binds to stromal cells and sinusoid endothelium in bone marrow and precursor B cell dynamics.
    L J Fauteux and D G Osmond
    J Immunol April 1, 1996, 156 (7) 2376-2383;
  • You have accessRestricted access
    Effects of nicotine on the immune response. II. Chronic nicotine treatment induces T cell anergy.
    Y Geng, S M Savage, S Razani-Boroujerdi and M L Sopori
    J Immunol April 1, 1996, 156 (7) 2384-2390;
  • You have accessRestricted access
    Identification and functional analysis of Ly-6A/E as a thymic and bone marrow stromal antigen.
    D J Izon, K Oritani, M Hamel, C R Calvo, R L Boyd, P W Kincade and A M Kruisbeek
    J Immunol April 1, 1996, 156 (7) 2391-2399;
  • You have accessRestricted access
    IL-15 promotes cytokine production of human T helper cells.
    A Mori, M Suko, O Kaminuma, S Inoue, T Ohmura, Y Nishizaki, T Nagahori, Y Asakura, A Hoshino, Y Okumura, G Sato, K Ito and H Okudaira
    J Immunol April 1, 1996, 156 (7) 2400-2405;
  • You have accessRestricted access
    Glucocorticoids promote a TH2 cytokine response by CD4+ T cells in vitro.
    F Ramírez, D J Fowell, M Puklavec, S Simmonds and D Mason
    J Immunol April 1, 1996, 156 (7) 2406-2412;
  • You have accessRestricted access
    High-dose IL-2 and IL-15 enhance the in vitro priming of naive CD4+ T cells for IFN-gamma but have differential effects on priming for IL-4.
    R A Seder
    J Immunol April 1, 1996, 156 (7) 2413-2422;
  • You have accessRestricted access
    H-2Dp transgene alters natural killer cell specificity at the target and effector cell levels. Comparison with an H-2Dd transgene.
    C L Sentman, M Y Olsson-Alheim, U Lendahl and K Kärre
    J Immunol April 1, 1996, 156 (7) 2423-2429;
  • You have accessRestricted access
    Bacterial superantigen-induced human lymphocyte responses are nitric oxide dependent and mediated by IL-12 and IFN-gamma.
    S Sriskandan, T J Evans and J Cohen
    J Immunol April 1, 1996, 156 (7) 2430-2435;
  • You have accessRestricted access
    LPS induces NK1.1+ alpha beta T cells with potent cytotoxicity in the liver of mice via production of IL-12 from Kupffer cells.
    M Takahashi, K Ogasawara, K Takeda, W Hashimoto, H Sakihara, K Kumagai, R Anzai, M Satoh and S Seki
    J Immunol April 1, 1996, 156 (7) 2436-2442;
  • You have accessRestricted access
    Suppression of the antibody response to a polymorphic peptide from the platelet alloantigen integrin beta3 with low molecular weight antigen arrays.
    D C Watson, J Reim and H M Dintzis
    J Immunol April 1, 1996, 156 (7) 2443-2450;
  • You have accessRestricted access
    IFN-gamma induces the kappa intron enhancer via an IFN-stimulated response element.
    M A Damore, S A Omori and R Wall
    J Immunol April 1, 1996, 156 (7) 2451-2457;
  • You have accessRestricted access
    Extensive diversity of transcribed TCR-beta in phylogenetically primitive vertebrate.
    N A Hawke, J P Rast and G W Litman
    J Immunol April 1, 1996, 156 (7) 2458-2464;
  • You have accessRestricted access
    Functional analysis of the lymphotoxin-beta promoter. Sequence requirements for PMA activation.
    D V Kuprash, O A Osipovich, D K Pokholok, M B Alimzhanov, A Biragyn, R L Turetskaya and S A Nedospasov
    J Immunol April 1, 1996, 156 (7) 2465-2472;
  • You have accessRestricted access
    Importance of MHC class 1 alpha2 and alpha3 domains in the recognition of self and non-self MHC molecules.
    M H Newberg, D H Smith, S B Haertel, D R Vining, E Lacy and V H Engelhard
    J Immunol April 1, 1996, 156 (7) 2473-2480;
  • You have accessRestricted access
    Loss ability to produce IFN-alpha in response to HIV-1 as monocytes differentiate into macrophages. Induction through a mechanism independent of double-stranded RNA.
    M L Francis, X S Fan and M S Meltzer
    J Immunol April 1, 1996, 156 (7) 2481-2487;
  • You have accessRestricted access
    Recombinant IL-4 treatment augments resistance to Borrelia burgdorferi infections in both normal susceptible and antibody-deficient susceptible mice.
    A Keane-Myers, C R Maliszewski, F D Finkelman and S P Nickell
    J Immunol April 1, 1996, 156 (7) 2488-2494;
  • You have accessRestricted access
    Apoptosis-independent retinoblastoma protein rescue of HLA class II messenger RNA IFN-gamma inducibility in non-small cell lung carcinoma cells. Lack of surface class II expression associated with a specific defect in HLA-DRA induction.
    Y Lu, J M Boss, S X Hu, H J Xu and G Blanck
    J Immunol April 1, 1996, 156 (7) 2495-2502;
  • You have accessRestricted access
    IL-1 receptor antagonist (IL-1ra) expression, function, and cytokine-mediated regulation during mycobacterial and schistosomal antigen-elicited granuloma formation.
    J H Ruth, M Bienkowski, K S Warmington, P M Lincoln, S L Kunkel and S W Chensue
    J Immunol April 1, 1996, 156 (7) 2503-2509;
  • You have accessRestricted access
    Gene-targeted mice lacking B cells are unable to eliminate a blood stage malaria infection.
    T von der Weid, N Honarvar and J Langhorne
    J Immunol April 1, 1996, 156 (7) 2510-2516;
  • You have accessRestricted access
    Pro-opiomelanocortin-derived peptides induce IL-10 production in human monocytes.
    R S Bhardwaj, A Schwarz, E Becher, K Mahnke, Y Aragane, T Schwarz and T A Luger
    J Immunol April 1, 1996, 156 (7) 2517-2521;
  • You have accessRestricted access
    Effects of granulocyte-macrophage colony-stimulating factor on eicosanoid production by mononuclear phagocytes.
    T G Brock, R W McNish, M J Coffey, T C Ojo, S M Phare and M Peters-Golden
    J Immunol April 1, 1996, 156 (7) 2522-2527;
  • You have accessRestricted access
    Localization of classical and alternative pathway regulatory activity within the decay-accelerating factor.
    W G Brodbeck, D Liu, J Sperry, C Mold and M E Medof
    J Immunol April 1, 1996, 156 (7) 2528-2533;
  • You have accessRestricted access
    Regulated expression and release of the IL-1 decoy receptor in human mononuclear phagocytes.
    F Colotta, S Saccani, J G Giri, S K Dower, J E Sims, M Introna and A Mantovani
    J Immunol April 1, 1996, 156 (7) 2534-2541;
  • You have accessRestricted access
    Identification of haptoglobin as an alternative ligand for CD11b/CD18.
    S M El Ghmati, E M Van Hoeyveld, J G Van Strijp, J L Ceuppens and E A Stevens
    J Immunol April 1, 1996, 156 (7) 2542-2552;
  • You have accessRestricted access
    Endogenous IFN-alpha beta suppresses colony-stimulating factor (CSF)-1-stimulated macrophage DNA synthesis and mediates inhibitory effects of lipopolysaccharide and TNF-alpha.
    J A Hamilton, G A Whitty, I Kola and P J Hertzog
    J Immunol April 1, 1996, 156 (7) 2553-2557;
  • You have accessRestricted access
    Cytokine-regulated expression of E-selectin, intercellular adhesion molecule-1 (ICAM-1), and vascular cell adhesion molecule-1 (VCAM-1) in human microvascular endothelial cells.
    G Haraldsen, D Kvale, B Lien, I N Farstad and P Brandtzaeg
    J Immunol April 1, 1996, 156 (7) 2558-2565;
  • You have accessRestricted access
    Human eosinophils elaborate the lymphocyte chemoattractants. IL-16 (lymphocyte chemoattractant factor) and RANTES.
    K G Lim, H C Wan, P T Bozza, M B Resnick, D T Wong, W W Cruikshank, H Kornfeld, D M Center and P F Weller
    J Immunol April 1, 1996, 156 (7) 2566-2570;
  • You have accessRestricted access
    TNF-alpha stimulates monocyte adhesion to glomerular mesangial cells. The role of intercellular adhesion molecule-1 gene expression and protein kinases.
    R Pai, B Bassa, M A Kirschenbaum and V S Kamanna
    J Immunol April 1, 1996, 156 (7) 2571-2579;
  • You have accessRestricted access
    Ligation of the functional domain of complement receptor type 2 (CR2, CD21) is relevant for complex formation in T cell lines.
    W M Prodinger, C Larcher, M Schwendinger and M P Dierich
    J Immunol April 1, 1996, 156 (7) 2580-2584;
  • You have accessRestricted access
    Extracellular activities of human granzyme A. Monocyte activation by granzyme A versus alpha-thrombin.
    L E Sower, C J Froelich, N Allegretto, P M Rose, W D Hanna and G R Klimpel
    J Immunol April 1, 1996, 156 (7) 2585-2590;
  • You have accessRestricted access
    Differential regulation of IL-6 gene transcription and expression by IL-4 and IL-10 in human monocytic cell lines.
    S Takeshita, J R Gage, T Kishimoto, D L Vredevoe and O Martínez-Maza
    J Immunol April 1, 1996, 156 (7) 2591-2598;
  • You have accessRestricted access
    Neutrophil lactoferrin release induced by IgA immune complexes can be mediated either by Fc alpha receptors or by complement receptors through different pathways.
    W Zhang and P J Lachmann
    J Immunol April 1, 1996, 156 (7) 2599-2606;
  • You have accessRestricted access
    Stress-induced enhancement of antigen-specific cell-mediated immunity.
    F S Dhabhar and B S McEwen
    J Immunol April 1, 1996, 156 (7) 2608-2615;
  • You have accessRestricted access
    Cytotoxic T lymphocytes in asymptomatic long-term nonprogressing HIV-1 infection. Breadth and specificity of the response and relation to in vivo viral quasispecies in a person with prolonged infection and low viral load.
    T Harrer, E Harrer, S A Kalams, P Barbosa, A Trocha, R P Johnson, T Elbeik, M B Feinberg, S P Buchbinder and B D Walker
    J Immunol April 1, 1996, 156 (7) 2616-2623;
  • You have accessRestricted access
    Apoptosis sensitivity in chronic lymphocytic leukemia is determined by endogenous endonuclease content and relative expression of BCL-2 and BAX.
    D J McConkey, J Chandra, S Wright, W Plunkett, T J McDonnell, J C Reed and M Keating
    J Immunol April 1, 1996, 156 (7) 2624-2630;
  • You have accessRestricted access
    Monoclonal antibodies from NZW x BXSB F1 mice to beta2 glycoprotein I and cardiolipin. Species specificity and charge-dependent binding.
    M Monestier, D A Kandiah, S Kouts, K E Novick, G L Ong, M Z Radic and S A Krilis
    J Immunol April 1, 1996, 156 (7) 2631-2641;
  • You have accessRestricted access
    Di- and trinucleotide target preferences of somatic mutagenesis in normal and autoreactive B cells.
    D S Smith, G Creadon, P K Jena, J P Portanova, B L Kotzin and L J Wysocki
    J Immunol April 1, 1996, 156 (7) 2642-2652;
Back to top
PreviousNext
PreviousNext

This Issue

The Journal of Immunology
Vol. 156, Issue 7
1 Apr 1996
  • Table of Contents
  • Table of Contents (PDF)
Sign up for alerts

Jump to

  • CUTTING EDGE
  • ARTICLES
  • Highlights
  • Most Cited
  • Most Read
Loading
Immunodominant AH1 Antigen-Deficient Necroptotic, but Not Apoptotic, Murine Cancer Cells Induce Antitumor Protection
Osteoclasts Derive Predominantly from Bone Marrow–Resident CX3CR1+ Precursor Cells in Homeostasis, whereas Circulating CX3CR1+ Cells Contribute to Osteoclast Development during Fracture Repair
Intracellular IL-1 Receptor Antagonist Isoform 1 Released from Keratinocytes upon Cell Death Acts as an Inhibitor for the Alarmin IL-1α
Polysaccharide Capsules Equip the Human Symbiont Bacteroides thetaiotaomicron to Modulate Immune Responses to a Dominant Antigen in the Intestine
Natural and Induced Tolerogenic Dendritic Cells
Cutting Edge: IL-6–Driven Immune Dysregulation Is Strictly Dependent on IL-6R α-Chain Expression

Navigate

  • Home
  • Current Issue
  • Next in The JI
  • Archive
  • Brief Reviews
  • Pillars of Immunology
  • Translating Immunology

For Authors

  • Submit a Manuscript
  • Instructions for Authors
  • About the Journal
  • Journal Policies
  • Editors

General Information

  • Advertisers
  • Subscribers
  • Rights and Permissions
  • Accessibility Statement
  • FAR 889
  • Privacy Policy
  • Disclaimer

Journal Services

  • Email Alerts
  • RSS Feeds
  • ImmunoCasts
  • Twitter

Copyright © 2022 by The American Association of Immunologists, Inc.

Print ISSN 0022-1767        Online ISSN 1550-6606